...
首页> 外文期刊>Journal of nuclear medicine technology >Parathyroid imaging: the importance of dual-radiopharmaceutical simultaneous acquisition with 99mTc-sestamibi and 123I.
【24h】

Parathyroid imaging: the importance of dual-radiopharmaceutical simultaneous acquisition with 99mTc-sestamibi and 123I.

机译:甲状旁腺成像:99mTc-司他比和123I双重放射药物同步采集的重要性。

获取原文
获取原文并翻译 | 示例
           

摘要

Our objective was to compare the accuracy of 3 imaging protocols for the detection of parathyroid adenomas: single-tracer, dual-phase imaging with (99m)Tc-sestamibi; dual-tracer, single-phase imaging with simultaneous acquisition of (99m)Tc-sestamibi and (123)I images; and dual-tracer, dual-phase imaging with simultaneous acquisition of (99m)Tc-sestamibi and (123)I images.Thirty-seven patients with surgical proof of parathyroid adenomas were evaluated. Three different protocols were derived from a single study in each patient, resulting in an intrapatient intrastudy comparison. The first derived protocol was the conventional dual-phase protocol with (99m)Tc-sestamibi consisting of anterior and anterior-oblique pinhole images of the neck at 15 min and 3 h plus parallel-hole images of the neck and upper chest at both imaging times. The second derived protocol was a dual-tracer, single-phase protocol consisting of administration of (123)I followed 2 h later by (99m)Tc-sestamibi. Fifteen minutes later, anterior and anterior oblique pinhole images of the (99m)Tc-sestamibi and (123)I were acquired simultaneously, allowing generation of perfectly coregistered subtraction images. Parallel-hole images of the neck and upper chest were also obtained. The third protocol was the same as the second except that the same imaging protocol was repeated at 3 h. Two experienced nuclear medicine physicians indicated the location of any identified lesion and graded the certainty of diagnosis on a 3-point scale.Thirty-seven patients had 41 parathyroid adenomas. For the 2 observers combined, the localization success rate was 66% for the single-tracer, dual-phase protocol; 94% for the dual-tracer, single-phase protocol; and 90% for the dual-phase, dual-tracer protocol. Both dual-tracer protocols were significantly more accurate than the single-tracer protocol (P < 0.01); there was no significant difference between the 2 dual-tracer protocols. In addition, the degree of certainty of localization was greater with the 2 dual-tracer protocols than the single-tracer protocol (P < 0.001).A dual-tracer, single-phase parathyroid imaging protocol consisting of simultaneous acquisition of (99m)Tc-sestamibi and (123)I images with pinhole collimation at 15 min and perfectly coregistered subtraction results in a higher degree of accuracy and a greater degree of diagnostic certainty than the commonly used single-tracer, dual-phase protocol of imaging (99m)Tc-sestamibi alone at 15 min and 3 h. The addition of delayed imaging to the dual-tracer protocol did not improve results.
机译:我们的目标是比较3种成像方案检测甲状旁腺腺瘤的准确性:(99m)Tc-sestamibi的单示踪,双相成像;双示踪单相成像,可同时采集(99m)Tc-西司他比和(123)I图像;以及双示踪,双相成像,同时获取(99m)Tc-sestamibi和(123)I图像。对37例经甲状旁腺腺瘤手术证实的患者进行了评估。每个患者的一项研究得出了三种不同的方案,从而进行了患者内研究比较。首先得出的协议是常规的双阶段协议,其中(99m)Tc-sestamibi包括在15分钟和3小时时颈部的前后斜针孔图像以及两次成像时颈部和上胸部的平行孔图像次。第二个衍生方案是双示踪剂,单阶段方案,包括给药(123)I,然后2小时后给药(99m)Tc-sestamibi。 15分钟后,同时获取了(99m)Tc-sestamibi和(123)I的前后斜针孔图像,从而生成了完美配准的减影图像。还获得了颈部和上胸部的平行孔图像。第三方案与第二方案相同,除了在3小时重复相同的成像方案。两位经验丰富的核医学医师指出了所发现病灶的位置,并以3分制对诊断的准确性进行了分级。37位患者患有41处甲状旁腺腺瘤。对于两个观察员,单示踪剂,双阶段方案的定位成功率为66%。对于双跟踪器,单阶段协议,为94%; 90%用于双相双示踪协议。两种双示踪剂方案均比单示踪剂方案准确得多(P <0.01); 2种双重示踪剂协议之间没有显着差异。此外,使用2种双示踪剂方案比单用示踪剂方案的定位确定性更高(P <0.001)。双示踪剂,单相甲状旁腺成像方案包括同时采集(99m)Tc -sestamibi和(123)I图像在15分钟时进行针孔准直并完美地配准相减,与通常使用的单示踪,双相成像协议(99m)Tc相比,具有更高的准确度和更高的诊断确定性在15分钟和3小时单独使用-sestamibi。在双示踪剂方案中增加延迟成像不能改善结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号